Total Payments
$8,192
2024 Payments
$1,111
Companies
34
Transactions
644
Medicare Patients
4,758
Medicare Billing
$272,853
Payment Breakdown by Category
Food & Beverage$8,182 (99.9%)
Education$9.95 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,182 | 642 | 99.9% |
| Education | $9.95 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,407 | 81 | $0 (2024) |
| Novo Nordisk Inc | $1,090 | 83 | $0 (2024) |
| PFIZER INC. | $582.55 | 64 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $462.59 | 48 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $449.96 | 45 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $405.23 | 26 | $0 (2024) |
| Allergan, Inc. | $399.69 | 39 | $0 (2020) |
| Amgen Inc. | $378.72 | 29 | $0 (2023) |
| ABBVIE INC. | $357.37 | 23 | $0 (2024) |
| Merck Sharp & Dohme LLC | $303.73 | 32 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,111 | 59 | Novo Nordisk Inc ($179.51) |
| 2023 | $778.74 | 45 | Novo Nordisk Inc ($188.64) |
| 2022 | $543.26 | 33 | Takeda Pharmaceuticals U.S.A., Inc. ($145.65) |
| 2021 | $828.43 | 53 | AstraZeneca Pharmaceuticals LP ($185.26) |
| 2020 | $304.33 | 21 | AstraZeneca Pharmaceuticals LP ($41.50) |
| 2019 | $1,628 | 145 | AstraZeneca Pharmaceuticals LP ($245.84) |
| 2018 | $1,665 | 158 | AstraZeneca Pharmaceuticals LP ($268.29) |
| 2017 | $1,332 | 130 | AstraZeneca Pharmaceuticals LP ($354.46) |
All Payment Transactions
644 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.38 | General |
| 12/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: NEUROSCIENCE | ||||||
| 12/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.48 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: Respiratory | ||||||
| 11/11/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: Diabetes Care | ||||||
| 10/31/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: Diabetes | ||||||
| 10/31/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $10.16 | General |
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: Respiratory | ||||||
| 10/24/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $20.42 | General |
| Category: PSYCHIATRY | ||||||
| 10/21/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: Diabetes | ||||||
| 10/21/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $3.75 | General |
| 10/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.66 | General |
| Category: DIABETES | ||||||
| 10/02/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: Diabetes Care | ||||||
| 09/30/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: Diabetes | ||||||
| 09/26/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $23.77 | General |
| Category: PSYCHIATRY | ||||||
| 09/24/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: Respiratory | ||||||
| 09/19/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: PSYCHIATRY | ||||||
| 09/17/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: Gastroenterology | ||||||
| 08/15/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: Obesity | ||||||
| 08/08/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: Respiratory | ||||||
| 07/23/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: Diabetes | ||||||
| 07/15/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: NEUROSCIENCE | ||||||
| 07/12/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.70 | General |
| Category: Diabetes | ||||||
| 06/27/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 986 | 1,595 | $153,607 | $67,295 |
| 2022 | 18 | 1,192 | 1,845 | $186,251 | $85,327 |
| 2021 | 19 | 1,215 | 1,955 | $154,266 | $69,253 |
| 2020 | 19 | 1,365 | 2,085 | $156,086 | $50,978 |
Total Patients
4,758
Total Services
7,480
Medicare Billing
$272,853
Procedure Codes
71
All Medicare Procedures & Services
71 procedure records from CMS Medicare Utilization — Page 3 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | Office | 2021 | 13 | 14 | $224.00 | $48.35 | 21.6% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2021 | 12 | 80 | $2,560 | $34.66 | 1.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 237 | 400 | $60,794 | $18,513 | 30.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 232 | 426 | $47,948 | $15,177 | 31.7% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 104 | 120 | $9,360 | $4,588 | 49.0% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2020 | 22 | 22 | $3,762 | $2,574 | 68.4% |
| G0179 | Physician re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial imp | Office | 2020 | 40 | 86 | $9,804 | $2,455 | 25.0% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 75 | 86 | $3,268 | $1,537 | 47.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 86 | 88 | $1,672 | $1,412 | 84.4% |
| G0180 | Physician certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implem | Office | 2020 | 25 | 25 | $3,675 | $922.84 | 25.1% |
| 90688 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 45 | 46 | $966.00 | $878.44 | 90.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 316 | 421 | $4,210 | $816.35 | 19.4% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2020 | 11 | 22 | $3,483 | $736.21 | 21.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 20 | 20 | $740.00 | $318.84 | 43.1% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 44 | 55 | $1,540 | $309.84 | 20.1% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 16 | 16 | $368.00 | $307.70 | 83.6% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2020 | 14 | 31 | $620.00 | $126.09 | 20.3% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2020 | 27 | 96 | $480.00 | $123.85 | 25.8% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2020 | 15 | 17 | $561.00 | $110.66 | 19.7% |
| 81003 | Automated urinalysis test | Office | 2020 | 22 | 27 | $243.00 | $42.96 | 17.7% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2020 | 14 | 81 | $2,592 | $28.07 | 1.1% |
About Dr. Jerod Walker, DO
Dr. Jerod Walker, DO is a Family Medicine healthcare provider based in Wheelersburg, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/23/2011. The National Provider Identifier (NPI) number assigned to this provider is 1952684227.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jerod Walker, DO has received a total of $8,192 in payments from pharmaceutical and medical device companies, with $1,111 received in 2024. These payments were reported across 644 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($8,182).
As a Medicare-enrolled provider, Walker has provided services to 4,758 Medicare beneficiaries, totaling 7,480 services with total Medicare billing of $272,853. Data is available for 4 years (2020–2023), covering 71 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Wheelersburg, OH
- Active Since 09/23/2011
- Last Updated 11/24/2014
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1952684227
Products in Payments
- FARXIGA (Drug) $756.75
- VRAYLAR (Drug) $469.88
- Ozempic (Drug) $383.11
- XARELTO (Drug) $378.39
- JARDIANCE (Drug) $320.93
- JANUVIA (Drug) $250.08
- Aimovig (Biological) $220.51
- BREZTRI (Drug) $216.50
- BEVESPI AEROSPHERE (Drug) $204.82
- Trulance (Drug) $196.98
- Trintellix (Drug) $175.01
- Victoza (Drug) $173.73
- LYRICA (Drug) $168.55
- Kerendia (Drug) $160.83
- TRELEGY ELLIPTA (Drug) $155.16
- CHANTIX (Drug) $147.53
- LINZESS (Drug) $146.51
- Rybelsus (Drug) $139.76
- FREESTYLE LIBRE 3 (Device) $130.33
- NURTEC ODT (Drug) $126.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Wheelersburg
Mr. James Mcginnis, Do, DO
Family Medicine — Payments: $19,090
Family Medicine $19,090
Dr. David Provaznik, Do, DO
Family Medicine — Payments: $10,348
Family Medicine $10,348
Zachary Underwood, Do, DO
Family Medicine — Payments: $6,464
Family Medicine $6,464
Dr. Kemmely Hochstetler, M.d, M.D
Family Medicine — Payments: $2,429
Family Medicine $2,429
Dr. J Hernandez, Md, MD
Family Medicine
Family Medicine